This track welcomes papers addressing the latest advances in the fundamental and applied studies of product and process development of both established and emerging novel pharmaceutical modalities. Examples include biologics and other oligos, peptides, ADCs and other new modalities in pharmaceuticals. Scientists and engineers involved in upstream and downstream development, processing, scale-up and transfer of these products are invited. Topics may include, but not limited to, cell culture preparation/fermentation, separation/purification, formulation/buffer exchange, fill/finish, and finished device/delivery. Presentations in this Advances in New Modalities: New Modalities & Technologies session will focus on novel therapeutic modalities, delivery strategies, or technologies related to therapeutic molecules.
03:30 PM
Pelin Su Bulutoglu, Alayna M. George Thompson, Margaret Fettis-Koenders, Eric Murphy, Eric Sacia, Laurie Mlinar, Julie Heflin
03:51 PM
Mengyang Hu, Ayushi Gupta, Surya Karla, Thomas Neuman, Riddhi Banik, Christoph Keysberg, Leila Salim, Georges Belfort, Pankaj Karande
04:12 PM
Paridhi Agrawal, Michael Laurila, Steven Myers, Mark Berglund, Kevin Seibert
04:33 PM
Neha Padwal, Emily J. Guinn, Jing Teng
04:54 PM
05:15 PM